Should Preimplantation Genetic Testing (PGT) Systematically Be Proposed to <i>BRCA</i> Pathogenic Variant Carriers?
Over the past years, <i>BRCA</i> genes pathogenic variants have been associated to reproductive issues. Indeed, evidence indicate that <i>BRCA</i>-mutated patients are not only at higher risk of developing malignancies, but may also present a reduction of the follicular stock...
Main Authors: | Lucie Laot, Charlotte Sonigo, Julie Nobre, Alexandra Benachi, Traicie Dervin, Lina El Moujahed, Anne Mayeur, Dominique Stoppa-Lyonnet, Julie Steffann, Michael Grynberg |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-11-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/14/23/5769 |
Similar Items
-
Response to Ovarian Stimulation for Urgent Fertility Preservation before Gonadotoxic Treatment in <i>BRCA</i>-Pathogenic-Variant-Positive Breast Cancer Patients
by: Lina El Moujahed, et al.
Published: (2023-01-01) -
Non-Coding Variants in <i>BRCA1</i> and <i>BRCA2</i> Genes: Potential Impact on Breast and Ovarian Cancer Predisposition
by: Elizabeth Santana dos Santos, et al.
Published: (2018-11-01) -
Outcomes of BRCA pre-implantation genetic testing according to the parental mutation origin: a cohort study
by: Ilana Weizel, et al.
Published: (2024-01-01) -
Predominance of <i>BRCA2</i> Mutation and Estrogen Receptor Positivity in Unselected Breast Cancer with <i>BRCA1</i> or <i>BRCA2</i> Mutation
by: Pascal Pujol, et al.
Published: (2022-07-01) -
Preimplantation genetic testing (PGT) for hemophilia A: Experience from one center
by: Thi Minh Phuong Bui, et al.
Published: (2022-11-01)